MeijerinkTeam

Research Team @JulesMeijerink
🔬Pre-clinical Leukemia research

Our Mission: Oncogenetics and development of targeted therapies for T-cell leukemia/lymphoma

[MeijerinkTeam @MeijerinkTeam]

Huge thank you to editors that send out "paper accepted" emails on Mondays! No better way to start the week! @EmmaKroeze @JulesMeijerink @JanLoeffen

[MeijerinkTeam @MeijerinkTeam]

Good to see that also T-ALL patients are likely to benefit from CarT cells in the near future🙏

[Dr T. Comeau , MD @SCTNB]

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial | Journal of Clinical Oncology https://t.co/RFIiPIjGFX

[PrinsesMáximaCentrum @prinsesmaximac]

SIOP 2021 is about to kick off! SIOP is the most important childhood cancer research conference. Research from the Princess Máxima Center is well represented. Find out more: https://t.co/LMDdslshe0 @WorldSIOP #SIOP2021

[MeijerinkTeam @MeijerinkTeam]

Excited to finally find @valentina_cordo‘s review “T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies “, on PubMed!
https://t.co/LJS75VnEUR
#leukemia #therapy @BCD_AACR @JulesMeijerink
@prinsesmaximac

[MeijerinkTeam @MeijerinkTeam]

@BloodJournal @HerranzLab Nice work! @HerranzLab

[MeijerinkTeam @MeijerinkTeam]

We had such a blast on our lab retreat. It’s been 2 days of amazing scientific discussions and team building. Glad these in-person events are possible again!